Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Experimental melanoma vaccines.
Sivanandham M, Kim EM, Wallack MK. Sivanandham M, et al. IDrugs. 2002 Feb;5(2):159-70. IDrugs. 2002. PMID: 12861477
A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma.
Wallack MK, Sivanandham M, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty LE, Richards JM, Bartolucci AA, et al. Wallack MK, et al. Among authors: sivanandham m. Cancer. 1995 Jan 1;75(1):34-42. doi: 10.1002/1097-0142(19950101)75:1<34::aid-cncr2820750108>3.0.co;2-0. Cancer. 1995. PMID: 7804974 Clinical Trial.
Clinical trials with VMO for melanoma.
Wallack MK, Sivanandham M. Wallack MK, et al. Among authors: sivanandham m. Ann N Y Acad Sci. 1993 Aug 12;690:178-89. doi: 10.1111/j.1749-6632.1993.tb44007.x. Ann N Y Acad Sci. 1993. PMID: 8368736 Clinical Trial. No abstract available.
Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial.
Wallack MK, Sivanandham M, Ditaranto K, Shaw P, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty L, Richards JM, Rosen L, Bartolucci AA. Wallack MK, et al. Among authors: sivanandham m. Ann Surg. 1997 Aug;226(2):198-206. doi: 10.1097/00000658-199708000-00012. Ann Surg. 1997. PMID: 9296514 Free PMC article. Clinical Trial.
Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial.
Wallack MK, Sivanandham M, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty L, Richards JM, Bartolucci AA, Rosen L. Wallack MK, et al. Among authors: sivanandham m. J Am Coll Surg. 1998 Jul;187(1):69-77; discussion 77-9. doi: 10.1016/s1072-7515(98)00097-0. J Am Coll Surg. 1998. PMID: 9660028 Clinical Trial.
28 results